Literature DB >> 10512771

Proactive pre-conception counselling for women with epilepsy-is it effective?

T Betts1, C Fox.   

Abstract

We describe the development of a proactive pre-conception counselling service for women with epilepsy based on complete re-investigation of the woman's epilepsy, a policy of withdrawing antiepileptic drugs (AEDs) thought to carry an increased risk of foetal abnormality (and substitution, where indicated, of AEDs thought to carry a lesser risk) and the exhibition of folic acid 5 mg daily plus fulfilment of the woman's educational needs and exploration of her and her partner's wishes. The outcome of the assessment of 90 such women is compared with the outcome of 59 women presenting to our service already pregnant. An audit of the outcomes in the two groups suggests that re-investigation of women pre-conceptually is worthwhile (some women turn out not to have epilepsy or have cerebral lesions best managed before pregnancy) and that foetal morbidity may be reduced by judicious rationalization of medication: folic acid taken before conception may also be protective for the foetus. Proactive pre-conception counselling, however, only works if the woman is prepared to wait (sometimes up to a year) for necessary drug changes to be instituted and is using reliable contraception. Copyright 1999 BEA Trading Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512771     DOI: 10.1053/seiz.1999.0325

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  11 in total

Review 1.  Management of epilepsy during pregnancy: an update.

Authors:  Sima I Patel; Page B Pennell
Journal:  Ther Adv Neurol Disord       Date:  2015-12-27       Impact factor: 6.570

Review 2.  Management of epilepsy in women of childbearing age: practical recommendations.

Authors:  Barbara Tettenborn
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 3.  Management of epilepsy in women.

Authors:  M D O'Brien; S K Gilmour-White
Journal:  Postgrad Med J       Date:  2005-05       Impact factor: 2.401

Review 4.  Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations.

Authors:  James W McAuley; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 5.  Managing epilepsy in women of childbearing age.

Authors:  Pamela M Crawford
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 6.  Antiepileptic drugs in women with epilepsy during pregnancy.

Authors:  Evan Gedzelman; Kimford J Meador
Journal:  Ther Adv Drug Saf       Date:  2012-04

Review 7.  Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.

Authors:  C L Harden; P B Pennell; B S Koppel; C A Hovinga; B Gidal; K J Meador; J Hopp; T Y Ting; W A Hauser; D Thurman; P W Kaplan; J N Robinson; J A French; S Wiebe; A N Wilner; B Vazquez; L Holmes; A Krumholz; R Finnell; P O Shafer; C Le Guen
Journal:  Neurology       Date:  2009-04-27       Impact factor: 9.910

Review 8.  Do we practice what we preach? A review of actual clinical practice with regards to preconception care guidelines.

Authors:  Michele Curtis; Steve Abelman; Jay Schulkin; Jennifer L Williams; Elizabeth M Fassett
Journal:  Matern Child Health J       Date:  2006-07-29

Review 9.  Preconception care: delivery strategies and packages for care.

Authors:  Zohra S Lassi; Sohni V Dean; Dania Mallick; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2014-09-26       Impact factor: 3.223

Review 10.  Preconception care: screening and management of chronic disease and promoting psychological health.

Authors:  Zohra S Lassi; Ayesha M Imam; Sohni V Dean; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2014-09-26       Impact factor: 3.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.